Clinical trial
Prospective Evaluation of Tumor Angiogenesis in Endocrine Neoplasms
NCT00923780 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Tumor Angiogenesis in Endocrine Neoplasms
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 5, 2007
- Completion date
- Not reported
- Enrollment
- 400
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lesions